Han B, Zheng R, Zeng H, Wang S, Sun K, Chen R, et al. Cancer incidence and mortality in China, 2022. J Natl Cancer Cent. 2024;4:47–53. https://doi.org/10.1016/j.jncc.2024.01.006.
Google Scholar
Zheng R, Zhang S, Zeng H, Wang S, Sun K, Chen R, et al. Cancer incidence and mortality in China, 2016. J Natl Cancer Cent. 2022;2:1–9. https://doi.org/10.1016/j.jncc.2022.02.002.
Google Scholar
Bogović Crnčić T. Risk Factors for Thyroid Cancer: What Do We Know So Far? Acta Clin Croat. 2020. https://doi.org/10.20471/acc.2020.59.s1.08.
Kitahara CM, Sosa JA. The changing incidence of thyroid cancer. Nat Rev Endocrinol. 2016;12:646–53. https://doi.org/10.1038/nrendo.2016.110.
Google Scholar
Cabanillas ME, McFadden DG, Durante C. Thyroid cancer. The Lancet. 2016;388:2783–95. https://doi.org/10.1016/S0140-6736(16)30172-6.
Google Scholar
Siegel RL, Miller KD, Jemal A. Cancer statistics, 2020. CA Cancer J Clin. 2020;70:7–30. https://doi.org/10.3322/caac.21590.
Google Scholar
Malchoff CD, Malchoff DM. Familial Nonmedullary Thyroid Carcinoma. Cancer Control. 2006;13:106–10. https://doi.org/10.1177/107327480601300204.
Google Scholar
Pasquali D, Torella A, Accardo G, Esposito D, Del Vecchio Blanco F, Salvatore D, et al. BROX haploinsufficiency in familial nonmedullary thyroid cancer. J Endocrinol Invest. 2021;44:165–71. https://doi.org/10.1007/s40618-020-01286-6.
Google Scholar
Muallem Kalmovich L, Jabarin B, Koren S, Or K, Marcus E, Tkacheva I, et al. Is Familial Nonmedullary Thyroid Cancer A More Aggressive Type of Thyroid Cancer? The Laryngoscope. 2021;131. https://doi.org/10.1002/lary.28989.
Ammar SA, Alobuia WM, Kebebew E. An update on familial nonmedullary thyroid cancer. Endocrine. 2020;68:502–7. https://doi.org/10.1007/s12020-020-02250-3.
Google Scholar
Tomsic J, He H, Akagi K, Liyanarachchi S, Pan Q, Bertani B, et al. A germline mutation in SRRM2, a splicing factor gene, is implicated in papillary thyroid carcinoma predisposition. Sci Rep. 2015;5:10566. https://doi.org/10.1038/srep10566.
Google Scholar
Bevan S, Pal T, Greenberg CR, Green H, Wixey J, Bignell G, et al. A comprehensive analysis of MNG1, TCO1, fPTC, PTEN, TSHR, and TRKA in familial nonmedullary thyroid cancer: confirmation of linkage to TCO1. J Clin Endocrinol Metab. 2001;86:3701–4. https://doi.org/10.1210/jcem.86.8.7725.
Google Scholar
Gara SK, Jia L, Merino MJ, Agarwal SK, Zhang L, Cam M, et al. Germline HABP2 mutation causing familial nonmedullary thyroid cancer. N Engl J Med. 2015;373:448–55. https://doi.org/10.1056/NEJMoa1502449.
Google Scholar
Ye F, Gao H, Xiao L, Ding H, Huang Z, Jiang Y, et al. Authors’ reply to: Absence of the MA P2K5 germline variants c.G961A and c.T1100C in a wide series of familial non-medullary thyroid carcinoma Italian families. International Journal of Cancer 2019; in press. Int J Cancer. 2019;145:601–2. https://doi.org/10.1002/ijc.32243.
Google Scholar
Marques IJ, Gomes I, Pojo M, Pires C, Moura MM, Cabrera R, et al. Identification of SPRY4 as a novel candidate susceptibility gene for familial nonmedullary thyroid cancer. Thyroid. 2021;31:1366–75. https://doi.org/10.1089/thy.2020.0290.
Google Scholar
Miasaki FY, Fuziwara CS, Carvalho GAD, Kimura ET. Genetic mutations and variants in the susceptibility of familial non-medullary thyroid cancer. Genes. 2020;11:1364 https://doi.org/10.3390/genes11111364.
Google Scholar
Amasino AL, Gupta S, Friedman LJ, Gelles J, Bell SP. Regulation of replication origin licensing by ORC phosphorylation reveals a two-step mechanism for Mcm2-7 ring closing. Proc Natl Acad Sci. 2023;120:e2221484120. https://doi.org/10.1073/pnas.2221484120.
Google Scholar
Sun Y, Cheng Z, Liu S. MCM2 in human cancer: functions, mechanisms, and clinical significance. Mol Med. 2022;28:128 https://doi.org/10.1186/s10020-022-00555-9.
Google Scholar
Pruitt SC, Bailey KJ, Freeland A. Reduced Mcm2 Expression Results in Severe Stem/Progenitor Cell Deficiency and Cancer. Stem Cells. 2007;25:3121–32. https://doi.org/10.1634/stemcells.2007-0483.
Google Scholar
Kunnev D, Rusiniak ME, Kudla A, Freeland A, Cady GK, Pruitt SC. DNA damage response and tumorigenesis in Mcm2-deficient mice. Oncogene. 2010;29:3630–8. https://doi.org/10.1038/onc.2010.125.
Google Scholar
McKenna A, Hanna M, Banks E, Sivachenko A, Cibulskis K, Kernytsky A, et al. The Genome Analysis Toolkit: A MapReduce framework for analyzing next-generation DNA sequencing data. Genome Res. 2010;20:1297–303. https://doi.org/10.1101/gr.107524.110.
Google Scholar
McLaren W, Gil L, Hunt SE, Riat HS, Ritchie GRS, Thormann A, et al. The Ensembl Variant Effect Predictor. Genome Biol. 2016;17:122 https://doi.org/10.1186/s13059-016-0974-4.
Google Scholar
Wang K, Li M, Hakonarson H. ANNOVAR: functional annotation of genetic variants from high-throughput sequencing data. Nucleic Acids Res. 2010;38:e164–e164. https://doi.org/10.1093/nar/gkq603.
Google Scholar
Exome Aggregation Consortium, Lek M, Karczewski KJ, Minikel EV, Samocha KE, Banks E, et al. Analysis of protein-coding genetic variation in 60,706 humans. Nature. 2016;536:285–91. https://doi.org/10.1038/nature19057.
Google Scholar
The 1000 Genomes Project Consortium, Corresponding authors, Steering committee, Auton A, Abecasis GR, Altshuler DM, et al. A global reference for human genetic variation. Nature. 2015;526:68–74. https://doi.org/10.1038/nature15393.
Google Scholar
Dobin A, Davis CA, Schlesinger F, Drenkow J, Zaleski C, Jha S, et al. STAR: ultrafast universal RNA-seq aligner. Bioinformatics. 2013;29:15–21. https://doi.org/10.1093/bioinformatics/bts635.
Google Scholar
Liao Y, Smyth GK, Shi W. featureCounts: an efficient general purpose program for assigning sequence reads to genomic features. Bioinformatics. 2014;30:923–30. https://doi.org/10.1093/bioinformatics/btt656.
Google Scholar
Love MI, Huber W, Anders S. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 2014;15:550. https://doi.org/10.1186/s13059-014-0550-8.
Google Scholar
Valverde LDF, De Freitas RD, Pereira TDA, De Resende MF, Agra IMG, Dos Santos JN, et al. MCM3: a novel proliferation marker in oral squamous cell carcinoma. Appl Immunohistochem Mol Morphol. 2018;26:120–5. https://doi.org/10.1097/PAI.0000000000000397.
Google Scholar
Apellániz D, Pereira-Prado V, Sicco E, Vigil-Bastitta G, González-González R, Mosqueda-Taylor A, et al. Comparative Study of the Minichromosome Maintenance Proteins Complex (MCM 4/5/6) in Ameloblastoma and Unicystic Ameloblastoma. Int J Surg Pathol. 2018;26:714–20. https://doi.org/10.1177/1066896918778341.
Google Scholar
Cao X, Zhang Y, Song Y, Lin Y, Han X, Hou A, et al. Targeting minichromosome maintenance proteins in cancer stem cells: mechanisms and therapeutic opportunities. Biochem Pharmacol. 2025;242:117385. https://doi.org/10.1016/j.bcp.2025.117385.
Google Scholar
Fu Y, Zhu Jyi, Richman A, Zhao Z, Zhang F, Ray PE, et al. A Drosophila model system to assess the function of human monogenic podocyte mutations that cause nephrotic syndrome. Hum Mol Genet. 2017;26:768–80. https://doi.org/10.1093/hmg/ddw428.
Google Scholar
Lorenzini PA, Chew RSE, Tan CW, Yong JY, Zhang F, Zheng J, et al. Human PRPF40B regulates hundreds of alternative splicing targets and represses a hypoxia expression signature. RNA. 2019;25:905–20. https://doi.org/10.1261/rna.069534.118.
Google Scholar
Stead BE, Brandl CJ, Davey MJ. Phosphorylation of Mcm2 modulates Mcm2–7 activity and affects the cell’s response to DNA damage. Nucleic Acids Res. 2011;39:6998–7008. https://doi.org/10.1093/nar/gkr371.
Google Scholar
Bantele SCS, Pfander B. Quantitative mechanisms of DNA damage sensing and signaling. Curr Genet. 2020;66:59–62. https://doi.org/10.1007/s00294-019-01007-4.
Google Scholar
Adams DJ, Barlas B, McIntyre RE, Salguero I, Van Der Weyden L, Barros A, et al. Genetic determinants of micronucleus formation in vivo. Nature. 2024;627:130–6. https://doi.org/10.1038/s41586-023-07009-0.
Google Scholar
Pederson HJ, Narod SA. Commentary: Why is genetic testing underutilized worldwide? The case for hereditary breast cancer. BJC Rep. 2024;2:73 https://doi.org/10.1038/s44276-024-00099-x.
Google Scholar
Daca-Álvarez M, Latchford A, Pellisé M, Balaguer F. Familial adenomatous polyposis: non-surgical management of large bowel disease: endoscopic and chemoprevention strategies. Fam Cancer. 2025;24:53 https://doi.org/10.1007/s10689-025-00480-w.
Google Scholar
Diquigiovanni C, Bonora E. Genetics of familial non-medullary thyroid carcinoma (FNMTC). Cancers. 2021;13:2178 https://doi.org/10.3390/cancers13092178.
Google Scholar
Yang G, Tian Y, Zhang Y, Ran Y, Fan Y, Li P, et al. Relationship between affected family members and clinical aggressiveness in Familial non-medullary thyroid carcinoma: a systematic review and meta-analysis. Endocrine. 2025. https://doi.org/10.1007/s12020-025-04413-6.
Google Scholar
Wang X, Cheng W, Li J, Su A, Wei T, Liu F, et al. ENDOCRINE TUMOURS: Familial nonmedullary thyroid carcinoma is a more aggressive disease: a systematic review and meta-analysis. Eur J Endocrinol. 2015;172:R253–62. https://doi.org/10.1530/EJE-14-0960.
Google Scholar
Ishimi Y. Regulation of MCM2-7 function. Genes Genet Syst. 2018;93:125–33. https://doi.org/10.1266/ggs.18-00026.
Google Scholar
Kumar C, Remus D. Eukaryotic replication origins: Strength in flexibility. Nucleus. 2016;7:292–300. https://doi.org/10.1080/19491034.2016.1187353.
Google Scholar
Rankin BD, Rankin S. The MCM2-7 Complex: Roles beyond DNA Unwinding. Biology. 2024;13:258 https://doi.org/10.3390/biology13040258.
Google Scholar
Blow JJ, Gillespie PJ. Replication licensing and cancer — a fatal entanglement? Nat Rev Cancer. 2008;8:799–806. https://doi.org/10.1038/nrc2500.
Google Scholar
Kunnev D, Freeland A, Qin M, Leach RW, Wang J, Shenoy RM, et al. Effect of minichromosome maintenance protein 2 deficiency on the locations of DNA replication origins. Genome Res. 2015;25:558–69. https://doi.org/10.1101/gr.176099.114.
Google Scholar
Aguilera A, García-Muse T. Causes of Genome Instability. Annu Rev Genet. 2013;47:1–32. https://doi.org/10.1146/annurev-genet-111212-133232.
Google Scholar
Shima N, Alcaraz A, Liachko I, Buske TR, Andrews CA, Munroe RJ, et al. A viable allele of Mcm4 causes chromosome instability and mammary adenocarcinomas in mice. Nat Genet. 2007;39:93–8. https://doi.org/10.1038/ng1936.
Google Scholar
Chuang CH, Wallace MD, Abratte C, Southard T, Schimenti JC. Incremental Genetic Perturbations to MCM2-7 Expression and Subcellular Distribution Reveal Exquisite Sensitivity of Mice to DNA Replication Stress. Frankel WN, editor. PLoS Genet. 2010 Sep 9;6:e1001110. https://doi.org/10.1371/journal.pgen.1001110.
Shoshani O, Bakker B, De Haan L, Tijhuis AE, Wang Y, Kim DH, et al. Transient genomic instability drives tumorigenesis through accelerated clonal evolution. Genes Dev. 2021;35:1093–108. https://doi.org/10.1101/gad.348319.121.
Google Scholar
